GTF2E2 and neoplasm: Based on the high-throughput data obtained from Crispr/Cas9 screening system in the DepMap database (https://depmap.org/), perturbation of GTF2E2 by RNAi in different tumors cell lines caused growth inhibition, indicating that it appears to serve as an oncogene in several tumor types (Fig. 2a).